These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34115971)

  • 1. Optical control of targeted protein degradation.
    Reynders M; Trauner D
    Cell Chem Biol; 2021 Jul; 28(7):969-986. PubMed ID: 34115971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted protein degradation: A promise for undruggable proteins.
    Samarasinghe KTG; Crews CM
    Cell Chem Biol; 2021 Jul; 28(7):934-951. PubMed ID: 34004187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHOTACs Enable Optical Control of Protein Degradation.
    Reynders M; Trauner D
    Methods Mol Biol; 2021; 2365():315-329. PubMed ID: 34432252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photopharmacology-based small-molecule proteolysis targeting chimeras: optical control of protein degradation.
    Li W; Elhassan RM; Fang H; Hou X
    Future Med Chem; 2020 Nov; 12(22):1991-1993. PubMed ID: 33054433
    [No Abstract]   [Full Text] [Related]  

  • 5. PROTACs to address the challenges facing small molecule inhibitors.
    Martín-Acosta P; Xiao X
    Eur J Med Chem; 2021 Jan; 210():112993. PubMed ID: 33189436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolysis-targeting chimeras mediate the degradation of bromodomain and extra-terminal domain proteins.
    Yang Y; Wu Z; Chen P; Zheng P; Zhang H; Zhou J
    Future Med Chem; 2020 Sep; 12(18):1669-1683. PubMed ID: 32893690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-Molecule PROTACS: New Approaches to Protein Degradation.
    Toure M; Crews CM
    Angew Chem Int Ed Engl; 2016 Feb; 55(6):1966-73. PubMed ID: 26756721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential of Proteolytic Chimeras as Pharmacological Tools and Therapeutic Agents.
    Coll-Martínez B; Delgado A; Crosas B
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein degradation technology: a strategic paradigm shift in drug discovery.
    Li H; Dong J; Cai M; Xu Z; Cheng XD; Qin JJ
    J Hematol Oncol; 2021 Sep; 14(1):138. PubMed ID: 34488823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling PROTACs with Light.
    Verma S; Manna D
    ChemMedChem; 2020 Jul; 15(14):1258-1261. PubMed ID: 32558301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PROTACs: A novel strategy for cancer therapy.
    Liu J; Ma J; Liu Y; Xia J; Li Y; Wang ZP; Wei W
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):171-179. PubMed ID: 32058059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROTAC-DB: an online database of PROTACs.
    Weng G; Shen C; Cao D; Gao J; Dong X; He Q; Yang B; Li D; Wu J; Hou T
    Nucleic Acids Res; 2021 Jan; 49(D1):D1381-D1387. PubMed ID: 33010159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule degraders of cyclin-dependent kinase protein: a review.
    Yu B; Du Z; Zhang Y; Li Z; Bian J
    Future Med Chem; 2022 Jan; 14(3):167-185. PubMed ID: 34939427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted protein knockdown using small molecule degraders.
    Raina K; Crews CM
    Curr Opin Chem Biol; 2017 Aug; 39():46-53. PubMed ID: 28605671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule PROTACs: novel agents for cancer therapy.
    Wan Y; Yan C; Gao H; Liu T
    Future Med Chem; 2020 May; 12(10):915-938. PubMed ID: 32270707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
    Bondeson DP; Smith BE; Burslem GM; Buhimschi AD; Hines J; Jaime-Figueroa S; Wang J; Hamman BD; Ishchenko A; Crews CM
    Cell Chem Biol; 2018 Jan; 25(1):78-87.e5. PubMed ID: 29129718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Cullin-RING Ubiquitin Ligases and the Applications in PROTACs.
    Gong L; Cui D; Xiong X; Zhao Y
    Adv Exp Med Biol; 2020; 1217():317-347. PubMed ID: 31898236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action.
    Riching KM; Mahan S; Corona CR; McDougall M; Vasta JD; Robers MB; Urh M; Daniels DL
    ACS Chem Biol; 2018 Sep; 13(9):2758-2770. PubMed ID: 30137962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light-Induced Protein Degradation with Photocaged PROTACs.
    Xue G; Wang K; Zhou D; Zhong H; Pan Z
    J Am Chem Soc; 2019 Nov; 141(46):18370-18374. PubMed ID: 31566962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modular PROTAC design for target destruction using a degradation signal based on a single amino acid.
    Shanmugasundaram K; Shao P; Chen H; Campos B; McHardy SF; Luo T; Rao H
    J Biol Chem; 2019 Oct; 294(41):15172-15175. PubMed ID: 31511327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.